Skip to content

NB PHARMA

Active
Private limited companyfounded 199927 yrs activeAlbert I laan 255, 8620 Nieuwpoort, BelgiumKBO/BCE: BE 0465.917.724
Summary

NB PHARMA has been active since 1999 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €573,958 and a net result of €56,725. Equity is growing by ~67.3% per year across the filed fiscal years. Its solvency ranks better than 87% of 11293 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisWatch ReportCompare
NB PHARMAActiveChecked score 93/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730Warehousing and support activities for transportation NACE 52310
1 site
Size
€745,538total assets 2025
Staff
1.8 FTE
Equity
€573,958
Profit
€56,725
Turnover not published (abridged schema)
Financial health
93 Excellent Checked score 2025
Bankruptcy chance 12 m
0.1%
Structure
Parent
SODIAP · 100%
Board
1 member
Accounts 80 d early1 of 7 deeds read
Why 93- Liquidity: current ratio 3.02, cash €13,228- Sector Retail trade (NACE 47)+ Founded in 1999+ Equity €573,958 (77.0% of total assets)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Better than 66% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Strong
Solvency 100=
equity 77.0% of total assets
Liquidity 44=
short-term debt 23.0% · cash 1.8%
Profitability 78=
return on assets 7.6%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.7% (39,898 companies)
Last 22 months 01-2025: 0.5% 02-2025: 0.5%● 0.0% vs 01-2025 03-2025: 0.5%▼ -1.3% vs 02-2025 04-2025: 0.5%▲ +13.6% vs 03-2025 05-2025: 0.6%▲ +15.4% vs 04-2025 06-2025: 0.6%▲ +5.2% vs 05-2025highest value 07-2025: 0.6%▼ -11.4% vs 06-2025 08-2025: 0.6%● 0.0% vs 07-2025 09-2025: 0.2%▼ -60.8% vs 08-2025 10-2025: 0.2%● 0.0% vs 09-2025 11-2025: 0.2%● 0.0% vs 10-2025 12-2025: 0.2%● 0.0% vs 11-2025 01-2026: 0.2%● 0.0% vs 12-2025 02-2026: 0.2%● 0.0% vs 01-2026 03-2026: 0.2%● 0.0% vs 02-2026 04-2026: 0.2%▲ +11.9% vs 03-2026 05-2026: 0.2%▼ -2.0% vs 04-2026 06-2026: 0.1%▼ -42.5% vs 05-2026lowest value 07-2026: 0.1%● 0.0% vs 06-2026lowest value 08-2026: 0.1%● 0.0% vs 07-2026lowest value 09-2026: 0.1%● 0.0% vs 08-2026lowest value 10-2026: 0.1%● 0.0% vs 09-2026lowest value
  • Founded in 1999 lowers the probability for this profile
  • Equity €573,958 (77.0% of total assets) lowers the probability
  • Liquidity: current ratio 3.02, cash €13,228 raises the probability
  • Sector Retail trade (NACE 47) raises the probability
Credit up to €50,000 at 30 days acceptable
Liquidity ample (current ratio 3.02 against 2.72 in 2024; short-term debt: 23% and cash: 1.8% of total assets), and 23% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 92%, liquidity 42%, profitability 68%, growth against the median 62%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Founded in 1999
In the bankruptcy model this factor lowers the probability for this profile.
KBO
lowers risk · Equity €573,958 (77.0% of total assets)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
raises risk · Liquidity: current ratio 3.02, cash €13,228
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Sector Retail trade (NACE 47)
In the bankruptcy model this factor raises the probability.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-05-2026, 80 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
80 d early
2024
44 d early
2023
48 d early
2022
52 d early
2021
54 d early
2020
44 d early
2020
96 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 60 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 9 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
03-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Resignation: BV ALEXO (director)Permanent representatives: Olivier Delaere, Koen…
  2. Annual accounts filedfiscal year 2025 · abbreviated…
  3. Annual accounts filedfiscal year 2024 · abbreviated…

Key points

  • Caution: Board changedlatest change 19-05-2026 · 1 in office 1 joined · 1 left View
  • Positive: Among the best 14% on solvencysector median 37.2% · 11,293 companies 77.0% View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Controlled by SODIAPultimately: PHARMACIE BIA 100% View

By topic

Financials

Fiscal year
2025
Total assets
€745,538
Profit
€56,725
Solvency
77.0%
Total assets▲ 11.1%
Net result
20192025
Go to Financials

Timeline

Events
17
Since
2018
Next accounts
by 31-07-2027
  1. 17-07-2026Resignation: BV ALEXO (director)
  2. 12-05-2026Annual accounts filed
  3. 17-06-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
20-04-1999
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check Which other companies belong to the same group?PHARMACIE BIA · 40 companies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure